Related references
Note: Only part of the references are listed.Metabolic profile and pharmacokinetics of polyphyllin I, an anticancer candidate, in rats by UPLC-QTOF-MS/MS and LC-TQ-MS/MS
Yu-Cai Liu et al.
BIOMEDICAL CHROMATOGRAPHY (2017)
NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function
Shunan Ye et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
An orthotopic xenograft model with survival hindlimb amputation allows investigation of the effect of tumor microenvironment on sarcoma metastasis
Seth D. Goldstein et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Patient-Derived Sarcoma Xenografts for Individual-Patient Selection of Chemotherapy-Ready for Prime Time?
Andrew J. Wagner
CANCER (2014)
Patient-Derived Xenografts for Individualized Care in Advanced Sarcoma
Justin Stebbing et al.
CANCER (2014)
Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
Jason K. Sicklick et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Micro-Computed Tomography Derived Anisotropy Detects Tumor Provoked Deviations in Bone in an Orthotopic Osteosarcoma Murine Model
Heather A. Cole et al.
PLOS ONE (2014)
Translational biology of osteosarcoma
Maya Kansara et al.
NATURE REVIEWS CANCER (2014)
The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models
Ymera Pignochino et al.
CLINICAL CANCER RESEARCH (2013)
Epithelial-mesenchymal plasticity in carcinoma metastasis
Jeff H. Tsai et al.
GENES & DEVELOPMENT (2013)
The beta-Catenin Destruction Complex
Jennifer L. Stamos et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Treatment of Adult Soft Tissue Sarcoma: Old Concepts, New Insights, and Potential for Drug Discovery
Jeanny B. Aragon-Ching et al.
CANCER INVESTIGATION (2012)
Wnt signaling pathways in urological cancers: past decades and still growing
Shahana Majid et al.
MOLECULAR CANCER (2012)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
A review of clinical and molecular prognostic factors in osteosarcoma
Jonathan C. M. Clark et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma
Stefano Ferrari et al.
CURRENT OPINION IN ONCOLOGY (2007)
Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway
Alexandra Schambony et al.
DEVELOPMENTAL CELL (2007)
Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors
Michael D. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
L Sung et al.
EUROPEAN JOURNAL OF CANCER (2004)
Primary metastatic osteosarcoma:: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols
L Kager et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The subcellular destinations of APC proteins
M Bienz
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)